AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Dexglip 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Bajaj Pharmaceutical

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Dexglip 50/500 Tablet

Glimepiride/Metformin 50/500mg tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications, including renal impairment and vision loss, and may lessen the risk of cardiovascular events like heart attacks and strokes. This medication may be administered independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when coupled with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic efficacy; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes management, as lifestyle significantly impacts glycemic control. Common adverse effects include diarrhea, nausea, vomiting, dyspepsia, cephalgia, and pharyngitis. Hypoglycemia is a potential side effect, especially when used with insulin or sulfonylureas, necessitating awareness of its symptoms and management. This medication isn't suitable for all individuals. Prior to commencing treatment, disclose any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption to your physician. Pregnant or lactating women should seek medical consultation before use. Potential drug interactions exist; therefore, inform your doctor about all medications you are currently taking to ensure treatment safety. Alcohol consumption should be minimized due to its potential to lower blood glucose. Your doctor will monitor kidney function and blood glucose levels throughout the treatment period.

Primary Ingredients of Dexglip 50/500 Tablet

No information provided. Please provide the text you wish to be rephrased.

Uses of Dexglip 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Dexglip 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dexglip 50/500 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Dexglip 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Dexglip 50/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dexglip 50/500 Tablets should be administered with a meal.

How Dexglip 50/500 Tablet works:

Dexglip 50/500 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Dexglip 50/500 Tablets should not be consumed together due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dexglip 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Dexglip 50/500 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Dexglip 50/500 tablets cautiously, potentially requiring dosage modification. Consult your physician. Dexglip 50/500 tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Dexglip 50/500 tablets is contraindicated in individuals with hepatic impairment; avoid use and seek medical advice.

What if you forget to take Dexglip 50/500 Tablet :

Should you forget to take a Dexglip 50/500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dexglip 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dexglip 50/500 Tablet

Dexglip 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. It helps control blood sugar levels when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Dexglip 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Dexglip 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Dexglip 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Dexglip 50/500 tablets is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the label's storage instructions. Discard any unused medication and keep it out of reach of children, pets, and others.
Dexglip 50/500 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also called MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Dexglip 50/500 and seek immediate medical attention.
Dexglip 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Dexglip 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Dexglip 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Dexglip 50/500 tablets is unsafe due to the increased risk of lactic acidosis.
Dexglip 50/500 (containing metformin) can cause lactic acidosis, a serious medical emergency with high blood lactic acid levels (also known as MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Dexglip and seek immediate medical attention.
Prolonged use of Dexglip 50/500 tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Dexglip 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. It helps control blood sugar when used with a healthy diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Dexglip 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Dexglip 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Dexglip 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Dexglip 50/500 (containing metformin) can cause lactic acidosis, a serious medical emergency with elevated blood lactic acid levels (also known as MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Dexglip 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Dexglip 50/500 Tablet
151